VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.55 USD | +0.23% |
|
+2.88% | -4.59% |
| May. 09 | Ventas Unit Prices $500 Million Debt Offering | MT |
| May. 07 | RBC Capital Adjusts Price Target on Ventas to $52 From $50 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 4.83B | Sales 2025 * | 5.08B | Capitalization | 19.2B |
|---|---|---|---|---|---|
| Net income 2024 * | -198M | Net income 2025 * | -97M | EV / Sales 2024 * | 6.65 x |
| Net Debt 2024 * | 12.91B | Net Debt 2025 * | 13.08B | EV / Sales 2025 * | 6.35 x |
| P/E ratio 2024 * |
-37
x | P/E ratio 2025 * |
-56.5
x | Employees | 486 |
| Yield 2024 * |
3.86% | Yield 2025 * |
4.03% | Free-Float | 99.42% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More news
| 1 day | +0.23% | ||
| 1 week | +2.88% | ||
| Current month | +7.38% | ||
| 1 month | +8.04% | ||
| 3 months | +4.44% | ||
| 6 months | +13.00% | ||
| Current year | -4.59% |
1 week
45.95
47.70
1 month
41.4547.70
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 0 M€ | -.--% | ||
| 1.91% | 0 M€ | -2.05% | ||
| 1.43% | 0 M€ | +4.45% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 47.44 | +0.66% | 2,637,420 |
| 24-05-07 | 47.13 | +0.17% | 1,726,498 |
| 24-05-06 | 47.05 | +0.56% | 2,381,312 |
| 24-05-03 | 46.79 | +1.23% | 3,167,607 |
| 24-05-02 | 46.22 | +5.50% | 3,859,343 |
Delayed Quote Nyse, May 09, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-05-14
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
47.44
USD
Average target price
53
USD
Spread / Average Target
+11.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.59% | 19.2B | |
| +9.97% | 58.83B | |
| -1.77% | 13.48B | |
| +0.29% | 7.62B | |
| -13.64% | 5.84B | |
| +9.70% | 3.53B | |
| +1.54% | 3.44B | |
| -0.39% | 3.24B | |
| +17.19% | 2.85B | |
| -4.48% | 2.7B |
- Stock Market
- Equities
- VTR Stock